WATERTOWN, Mass.--(BUSINESS WIRE)--Treeline Biosciences (or Treeline) today announced the initiation of Phase 1 trials for two internally discovered programs, TLN-121 and TLN-372, and a third ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results